Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by talisman47on Sep 10, 2020 1:49pm
196 Views
Post# 31534169

response to my email from BC government regarding Algernon

response to my email from BC government regarding AlgernonI decided to write BC Government , Minister of Health , to make them aware of Algernonand this was my response from them....



Thank you for your email of August 19, 2020, regarding Algernon Pharmaceuticals and their clinical trials of ifenprodil for the treatment of coronavirus (COVID-19). The Honourable Adrian Dix, Minister of Health, has asked me to respond on his behalf.
 
Protecting the health and safety of British Columbians is the top priority of the Ministry of Health (the Ministry). The Provincial Health Officer, BC Centre for Disease Control (BCCDC), and the Ministry are actively monitoring the COVID-19 pandemic. Throughout British Columbia and Canada, there are many systems in place to prepare for, detect, and contain serious infectious diseases. We expect that transmission of COVID-19 will increase in the province and are providing advice and recommendations in response to the situation as it evolves in an effort to slow transmission; however, the Ministry and Provincial Health Officer are confident in our capacity to contain the spread of COVID-19 in our communities and at a provincial level.
 
Thank you for taking the time to bring Algernon Pharmaceuticals and their work with ifenprodil as a potential treatment for COVID19 to our attention. Provincial, federal, and health system partners are working collaboratively to take an evidenceinformed approach to addressing the pandemic, and are exploring all options to ensure that people are healthy. The Canadian Institutes of Health Research have announced a $27 million investment into COVID19 research; more information is available here: https://www.canada.ca/en/institutes-health-research/news/2020/03/government-of-canada-invests-27m-in-coronavirus-research--details-of-the-funded-projects.html. Additionally, Canada has signed onto the World Health Organization’s global ‘solidarity’ clinical trial; more information is available here: https://news.un.org/en/story/2020/03/1059722.
 
Although we are hopeful a cure or treatment can be found quickly, it is critical to note that, at this time, a proven treatment for COVID19 does not exist.
 
I appreciate the opportunity to respond.
 
Sincerely,
 
Tijana Fazlagic, PharmD, BSP, M.Sc. (Pharm)
Executive Director, Therapeutic Assessment & Access
Pharmaceutical, Laboratory & Blood Services Division, Ministry of Health
 
pc:       Honourable Adrian Dix
 
<< Previous
Bullboard Posts
Next >>